Wuwei Tang
@E Fund Management Co., Ltd.
Latest period2024 - Q3ReportedManaged Assets$1.946BTotal holdings353
Assets growth rate7.6%Assets growth rate (2-Q avg)9.81%Continuous growth in asset value5 quarters
Portfolio positions
This chart displays the top 10 holdings in E Fund Management Co., Ltd.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 353 positions.
Assets under management
The assets under management (AUM) of E Fund Management Co., Ltd. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 5 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.946B in assets, with a quarterly growth rate of 7.6% and a 2-quarter average growth rate of 9.81%. The portfolio is managed by Wuwei Tang, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
STAAStaar Surgical Co
| 0.14% | $2.579M 69,431 shares@ $37.15 avg price | Decreased -47.51% |
GILDGilead Sciences Inc
| 0.13% | $2.412M 28,774 shares@ $83.84 avg price | Decreased -11.31% |
REGNRegeneron Pharmaceuticals Inc
| 0.13% | $2.385M 2,269 shares@ $1051.24 avg price | Decreased -2.99% |
GDXVaneck Gold Miners Etf Usa
| 0.11% | $2.046M 51,380 shares@ $39.82 avg price | Decreased -33.23% |
HLTHilton Worldwide Holdings Inc
| 0.11% | $1.971M 8,553 shares@ $230.5 avg price | Decreased -21.56% |
CMCSAComcast Corp
| 0.09% | $1.743M 41,739 shares@ $41.77 avg price | Decreased -28.13% |
ORLYO'reilly Automotive Inc
| 0.08% | $1.438M 1,249 shares@ $1151.6 avg price | Decreased -0.63% |
CABACabaletta Bio Inc
| 0.07% | $1.322M 280,133 shares@ $4.72 avg price | Decreased -2.19% |
FATEFate Therapeutics Inc
| 0.07% | $1.238M 353,771 shares@ $3.5 avg price | Decreased -0.4% |
UTHRUnited Therapeutics Corp
| 0.06% | $1.148M 3,204 shares@ $358.35 avg price | Decreased -18.01% |